Schedule 13D ownership disclosure

PASSAGE BIO INC

Common Stock · CUSIP: 702712100

Event date: 2025-04-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ORBIMED ADVISORS LLCReported CIK 0001055951

    Shares: 6,650,000.00 · Class: 10.7%

  • ORBIMED CAPITAL GP VII LLCReported CIK 0001760648

    Shares: 6,650,000.00 · Class: 10.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-25-000425
Form type
SCHEDULE 13D/A
Filer
ORBIMED ADVISORS LLC
CIK
CIK 1055951
Filed
Apr 25, 2025
Reporting period
Apr 22, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub